May 1, 2012
By:Jill Wechsler
Expanding access to nonprescription drugs and facilitating comparative effectiveness research.
 |
April 1, 2012
By:Jill Wechsler
Demand for more information on study results and investigator payments create challenges.
|
March 1, 2012
By:Jill Wechsler
Congress, industry map out goals and concerns for revising FDA policies linked to user fee legislation.
|
February 1, 2012
By:Jill Wechsler
FDA wants sponsors to build quality into protocols, adopt risk-based strategies to streamline trials.
|
January 1, 2012
By:Jill Wechsler
Pressure to approve new user fees will affect policies for foreign studies and research methods.
|
December 1, 2011
By:Jill Wechsler
A comprehensive listing of US departments and offices that includes the telephone numbers of directors, commissioners, and advisors.
|
November 1, 2011
By:Jill Wechsler
Alternative approaches aim to tackle drug shortages, spur orphan drug development.
|
October 1, 2011
By:Jill Wechsler
Multiple regulatory and reimbursement proposals are slated to expand legislation to renew PDUFA.
|
September 1, 2011
By:Jill Wechsler
Modernizing the Common Rule to update research policies could spell important changes.
|
| 
Facebook
Quizzes
